KL-6 and poor prognosis in NSCLC patients treated with gefitinib.
Ohara
Gen
G
Kurishima
Koichi
K
Ishikawa
Hiroichi
H
Satoh
Hiroaki
H
Hizawa
Nobuyuki
N
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D018396:Mucin-1 / Q000097:blood*; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; C060192:MUC1 protein, human; D018396:Mucin-1; D011799:Quinazolines; D000077156:Gefitinib